12 Health Care Stocks Moving In Thursday's After-Market Session

Adagio Medical Holdings, Inc
Advanced Biomed, Inc.
Curis, Inc.
Cue Biopharma, Inc.
iSpecimen Inc

Adagio Medical Holdings, Inc

ADGM

0.00

Advanced Biomed, Inc.

ADVB

0.00

Curis, Inc.

CRIS

0.00

Cue Biopharma, Inc.

CUE

0.00

iSpecimen Inc

ISPC

0.00

Gainers

  • iSpecimen (NASDAQ:ISPC) stock rose 44.6% to $0.19 during Thursday's after-market session. The company's market cap stands at $4.3 million.
  • Simulations Plus (NASDAQ:SLP) stock increased by 13.16% to $14.7. The market value of their outstanding shares is at $261.9 million. The company's, Q2 earnings came out today.
  • Wellgistics Health (NASDAQ:WGRX) shares rose 12.83% to $0.12. The company's market cap stands at $15.1 million.
  • Curis (NASDAQ:CRIS) stock moved upwards by 11.09% to $0.57. The market value of their outstanding shares is at $21.8 million.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock moved upwards by 7.24% to $2.22. The market value of their outstanding shares is at $1.9 million.
  • Zentalis Pharmaceuticals (NASDAQ:ZNTL) stock moved upwards by 6.56% to $4.71. The company's market cap stands at $195.7 million.

Losers

  • Cue Biopharma (NASDAQ:CUE) shares declined by 10.7% to $0.26 during Thursday's after-market session. The market value of their outstanding shares is at $26.7 million.
  • Nexalin Technology (NASDAQ:NXL) shares fell 8.74% to $0.35. The company's market cap stands at $7.2 million.
  • Onconetix (NASDAQ:ONCO) shares decreased by 7.37% to $1.13.
  • Adagio Medical Holdings (NASDAQ:ADGM) stock fell 7.1% to $1.31. The market value of their outstanding shares is at $31.3 million.
  • Advanced Biomed (NASDAQ:ADVB) stock declined by 7.03% to $6.22. The market value of their outstanding shares is at $8.6 million.
  • SILO Pharma (NASDAQ:SILO) stock declined by 6.23% to $0.39. The company's market cap stands at $7.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.